Page last updated: 2024-08-24

2-methoxyestradiol and Cancer of Testis

2-methoxyestradiol has been researched along with Cancer of Testis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Horie-Inoue, K; Ichikawa, T; Ikeda, K; Inoue, S; Kawakami, S; Kitayama, S; Namekawa, T; Okamoto, K; Suzuki, T; Yano, A	1

Other Studies

1 other study(ies) available for 2-methoxyestradiol and Cancer of Testis

Article	Year
HIF1α inhibitor 2-methoxyestradiol decreases NRN1 expression and represses in vivo and in vitro growth of patient-derived testicular germ cell tumor spheroids. Cancer letters, 2020, 10-01, Volume: 489 Topics: 2-Methoxyestradiol; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; GPI-Linked Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Neoplasms, Germ Cell and Embryonal; Neuropeptides; Spheroids, Cellular; Testicular Neoplasms; Xenograft Model Antitumor Assays	2020

Article

Year

HIF1α inhibitor 2-methoxyestradiol decreases NRN1 expression and represses in vivo and in vitro growth of patient-derived testicular germ cell tumor spheroids.

Cancer letters, 2020, 10-01, Volume: 489

Topics: 2-Methoxyestradiol; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; GPI-Linked Proteins; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Neoplasms, Germ Cell and Embryonal; Neuropeptides; Spheroids, Cellular; Testicular Neoplasms; Xenograft Model Antitumor Assays

2020